Australia Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Published by: Global Markets Direct

Published: Mar. 19, 2009 - 97 Pages

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

3 Definitions of Markets Covered in This Report

3.1 Drug delivery devices

3.2 Needle-free Injections

3.3 Inhalation Systems

3.3.1 Metered Dose Inhaler

3.3.2 Dry powder inhaler

3.4 Infusion Systems

3.4.1 Infusion pumps

3.4.2 Syringe pumps

3.4.3 Disposable Infusion sets

4 Healthcare Sector Review

4.1 Healthcare Expenditure

4.2 Healthcare Infrastructure

4.3 Healthcare Policy

5 Regulation System

5.1 Medical Equipment Approval Process

5.1.1 Classification

5.1.2 Registration and Conformity Assessment

5.2 Advertising

5.3 Labeling and Packaging

5.4 Post-market Surveillance

5.5 Registration Fee

6 Pricing and Reimbursement

7 Distribution Structure

8 Drug Delivery Devices In Australia

8.1 Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015

8.2 Drug Delivery Devices, Australia, Overall Revenue ($ mn), 2000-2015

8.3 Drug Delivery Devices, Australia, Category Volume (Units), 2000-2015

8.4 Drug Delivery Devices, Australia, Company Share (2006-2007)

9 Infusion Systems In Australia

9.1 Infusion Systems Overall Revenue (2000-2015)

9.2 Infusion Systems Overall Volume (2000-2015)

9.3 Infusion Systems Average Price (2000-2015)

9.4 Infusion Systems Distribution Share (2007-2008)

9.5 Infusion Systems, Australia, Company Share (2006-2007)

10 Inhalation Systems In Australia

10.1 Inhalation Systems Overall Revenue (2000-2015)

10.2 Inhalation Systems Overall Volume (2000-2015)

10.3 Inhalation Systems Average Price (2000-2015)

10.4 Inhalation Systems Distribution Share (2007-2008)

10.5 Inhalation Systems, Australia, Company Share (2006-2007)

11 Overview of Key Companies in Australia Drug Delivery Devices Market

11.1 AstraZeneca PLC Company Profile

11.1.1 Company Overview

11.2 Boehringer Ingelheim GmbH Company Profile

11.2.1 Company Overview

11.2.2 Value Chain Analysis

11.2.2.1 Manufacturing

11.2.2.2 Product Development

11.2.2.3 Sales and Marketing

11.3 GlaxoSmithKline plc Company Profile

11.3.1 Company Overview

11.4 Cardinal Health, Inc. Company Profile

11.4.1 Company Overview

11.4.2 Value Chain Analysis

11.4.2.1 Manufacturing

11.4.2.2 Product Development

11.4.2.3 Sales and Marketing

11.5 Baxter International Inc. Company Profile

11.5.1 Company Overview

11.5.2 Value Chain Analysis

11.5.2.1 Manufacturing

11.5.2.2 Product Development

11.5.2.3 Sales and Marketing

11.6 Novartis AG

11.6.1 Company Overview

11.7 Fresenius SE

11.7.1 Company Overview

11.8 Smiths Medical Company Profile

11.8.1 Company Overview

11.8.2 Value Chain Analysis

11.8.2.1 Manufacturing

11.8.2.2 Product Development

11.8.2.3 Sales and Marketing

11.9 Consort Medical plc Company Profile

11.9.1 Company Overview

11.9.2 Value Chain Analysis

11.9.2.1 Manufacturing

11.9.2.2 Product Development

11.9.2.3 Sales and Marketing

11.9.3 Consort Medical plc Pipeline Products

11.9.3.1 Consort Medical plc Pipeline Products By Equipment Type

11.9.3.2 Consort Medical plc Pipeline Products By Development Stage

11.9.3.3 Consort Medical plc Pipeline Products By Therapy Area

11.10 B. Braun Melsungen AG Company Profile

11.10.1 Company Overview

11.10.2 Value Chain Analysis

11.10.2.1 Manufacturing

11.10.2.2 Product Development

11.10.2.3 Research and Development

11.10.2.4 Sales and Marketing

11.11 Hospira, Inc. Company Profile

11.11.1 Company Overview

11.11.2 Value Chain Analysis

11.11.2.1 Manufacturing

11.11.2.2 Product Development

11.11.2.3 Research and Development

11.11.2.4 Sales and Marketing

11.11.3 Hospira, Inc. Pipeline Products

11.11.3.1 Hospira, Inc. Pipeline Products by Equipment Type

11.11.3.2 Hospira, Inc. Pipeline Products by Development Stage

11.11.3.3 Hospira, Inc. Pipeline Products by Therapy Area

11.12 pSivida Limited Company Profile

11.12.1 Company Overview

11.13 Unomedical Pty Ltd Company Profile

11.13.1 Company Overview

12 Recent Developments

12.1 Product News

12.1.1 Dec 12, 2008: pSivida New Clinical Trial for Drug Delivery Device in AMD

12.1.2 Dec 03, 2008: pSivida’s BrachySil Pancreatic Cancer Treatment Featured On The BBC

12.1.3 Oct 02, 2008: Results from the Six-Month Interim Readout of the Human PK Iluvien Study

13 Appendix

13.1 Global Markets Direct Research Methodology

13.2 Coverage

13.3 Secondary Research

13.4 Primary Research

13.5 Models

13.6 Forecasts

13.7 Expert Panel Validation

13.8 Currency Conversion

13.9 Contact Us

13.10 Disclaimer

1.1 List of Tables

Table 1: Healthcare Infrastructure in Australia, 2005 16

Table 2: Healthcare Personnel in Australia, 2005 17

Table 3: Hospital Wards by Specialty in Australia, 2003-2007 18

Table 4: Doctors by Specialty in Australia, 2003-2007 19

Table 5: Conformity Assessment of Medical Devices based Device Class, in Australia, 2007 30

Table 6: Fee for Registered Device in Australia, 2007 32

Table 7: Fee for Device Clinical Trial in Australia, 2007 33

Table 8: Evaluation Fee for High and Low Level Registration of Medical Device in Australia, 2007 33

Table 9: Evaluation Fee for Variation Registration of Medical Device in Australia, 2007 34

Table 10: Fee for Registration of Listed Devices in Australia, 2007 34

Table 11: Fee for Registration of Listed Devices for Export Only in Australia, 2007 35

Table 12: Fee for Registration of Included Devices in Australia, 2007 35

Table 13: Fee for Initial Conformity Assessment of Medical Device in Australia, 2007 35

Table 14: Fee for Medical Device Changes Conformity Assessment in Australia, 2007 36

Table 15: Fee for Medical Device Conformity Assessment Surveillance Audit in Australia, 2007 36

Table 16: Fee for Medical Device Conformity Assessment Review Certificate in Australia, 2007 36

Table 17: Fee for Initial Conformity Assessment of Medical Device Components in Australia, 2007 37

Table 18: Fee for Conformity Assessment of Changes in Medical Device Components in Australia, 2007 37

Table 19: Fee for Abridged Conformity Assessment of Medical Device Components in Australia, 2007 37

Table 20: Fee for Inclusion of Medical Device in the Register in Australia, 2007 38

Table 21: Fee for ARTG Inclusion for Medical Device in Australia, 2007 38

Table 22: Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015 41

Table 23: Drug Delivery Devices, Australia, Overall Revenue ($ mn), 2000-2015 42

Table 24: Drug Delivery Devices, Australia, Portfolio Analysis, 2000-2015 43

Table 25: Drug Delivery Devices, Australia, Overall Revenue ($ mn), Historic, 2000-2008 44

Table 26: Drug Delivery Devices, Australia, Overall Revenue ($ mn), Forecast, 2008-2015 45

Table 27: Drug Delivery Devices, Australia, Category Volume (Units), 2000-2015 46

Table 28: Drug Delivery Devices, Australia, Category Volume (Units), Historic, 2000-2008 47

Table 29: Drug Delivery Devices, Australia, Category Volume (Units), Forecast, 2008-2015 48

Table 30: Drug Delivery Devices, Australia, Company Share by Revenue ($ mn), 2006-2007 49

Table 31: Infusion Systems, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008 50

Table 32: Infusion Systems, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015 51

Table 33: Infusion Systems, Australia, Volume (Units) by Segment, Historic, 2000-2008 52

Table 34: Infusion Systems, Australia, Volume (Units) by Segment, Forecast, 2008-2015 52

Table 35: Infusion Systems, Australia, Average Price ($), Historic, 2000-2008 53

Table 36: Infusion Systems, Australia, Average Price ($), Forecast, 2008-2015 53

Table 37: Infusion Systems, Australia, Distribution Share by Revenue ($mn), 2007-2008 54

Table 38: Infusion Systems, Australia, Company Share by Revenue ($ mn), 2006-2007 55

Table 39: Inhalation Systems, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008 56

Table 40: Inhalation Systems, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015 57

Table 41: Inhalation Systems, Australia, Volume (Units) by Segment, Historic, 2000-2008 58

Table 42: Inhalation Systems, Australia, Volume (Units) by Segment, Forecast, 2008-2015 59

Table 43: Inhalation Systems, Australia, Average Price ($), Historic, 2000-2008 60

Table 44: Inhalation Systems, Australia, Average Price ($), Forecast, 2008-2015 60

Table 45: Inhalation Systems, Australia, Distribution Share by Revenue ($mn), 2007-2008 61

Table 46: Inhalation Systems, Australia, Company Share by Revenue ($ mn), 2006-2007 62

Table 47: Consort Medical plc Pipeline Products by Equipment Type 80

Table 48: Consort Medical plc Pipeline Products By Development Stage 80

Table 49: Consort Medical plc Pipeline Products By Therapy Area 80

Table 50: Hospira, Inc. Pipeline Products by Equipment Type 88

Table 51: Hospira, Inc. Pipeline Products By Development Stage 88

Table 52: Hospira, Inc. Pipeline Products By Therapy Area 88

Table 53: USD to Local Currency, Average Exchange Rate 2008

1.2 List of Figures

Figure 1: Total Healthcare Expenditure in Australia, 2000 - 2005

Figure 2: Healthcare Financing Framework in Australia, 2007

Figure 3: Healthcare System in Australia, 2007

Figure 4: Classification of Medical Devices in Australia, 2007

Figure 5: Classification of Noninvasive Devices in Australia, 2007

Figure 6: Classification of Invasive Devices in Australia, 2007

Figure 7: Classification of Invasive Devices in Australia, 2007

Figure 8: Classification of Active Devices in Australia, 2007

Figure 9: Classification of Special Medical Devices in Australia, 2007

Figure 10: Conformity Assessment Procedure for Medical Devices in Australia, 2007

Figure 11: Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015

Figure 12: Drug Delivery Devices, Australia, Overall Revenue ($ mn), 2000-2015

Figure 13: Drug Delivery Devices, Australia, Portfolio Analysis, 2000-2015

Figure 14: Drug Delivery Devices, Australia, Overall Revenue ($ mn), Historic, 2000-2008

Figure 15: Drug Delivery Devices, Australia, Overall Revenue ($ mn), Forecast, 2008-2015

Figure 16: Drug Delivery Devices, Australia, Category Volume (Units), 2000-2015

Figure 17: Drug Delivery Devices, Australia, Category Volume (Units), Historic, 2000-2008

Figure 18: Drug Delivery Devices, Australia, Category Volume (Units), Forecast, 2008-2015

Figure 19: Drug Delivery Devices, Australia, Company Share (%), 2007

Figure 20: Infusion Systems, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008

Figure 21: Infusion Systems, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015

Figure 22: Infusion Systems, Australia, Company Share (%), 2007

Figure 23: Inhalation Systems, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008

Figure 24: Inhalation Systems, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015

Figure 25: Inhalation Systems, Australia, Volume (Units) by Segment, Historic, 2000-2008

Figure 26: Inhalation Systems, Australia, Volume (Units) by Segment, Forecast, 2008-2015

Figure 27: Inhalation Systems, Australia, Company Share (%), 2007

Figure 28: Boehringer Ingelheim GmbH Value Chain Analysis

Figure 29: Cardinal Health, Inc. Value Chain Analysis

Figure 30: Baxter International Inc. Value Chain Analysis

Figure 31: Smiths Medical Value Chain Analysis

Figure 32: Consort Medical plc Value Chain Analysis

Figure 33: B. Braun Melsungen AG Value Chain Analysis

Figure 34: Hospira, Inc. Value Chain Analysis

Figure 35: Global Markets Direct Methodology

Abstract

• The report provides drug delivery devices information broken down into detailed categories and segments in Australia.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

• Gain a strong understanding of the drug delivery devices market in Australia.
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.